Search Results - "Lambertini M"

Nail‐plate dystrophy of the fifth toenail: thinking outside the box.

Authors: Dika, E. Lambertini, M. Misciali, C. et al.

Source: Clinical & Experimental Dermatology. Apr2021, Vol. 46 Issue 3, p584-587. 4p. 2 Color Photographs.

Melanoma and eruptive naevi during cetuximab treatment: epidermal growth factor inhibitors and a common concern.

Authors: Ferrari, T. Lambertini, M. Tartari, F. et al.

Source: Clinical & Experimental Dermatology. Dec2021, Vol. 46 Issue 8, p1584-1586. 3p. 2 Color Photographs.

Adherence to guidelines in requesting Oncotype DX in a publicly funded health care system.

Authors: Martel, S. Lambertini, M. Simon, R. et al.

Source: Current Oncology. Aug2018, Vol. 25 Issue 4, p:e311-e318. 8p. 6 Charts.

The value of art in modern dermatology and medicine.

Authors: Lambertini, M. Lambertini, L. Dika, E.

Source: Journal of the European Academy of Dermatology & Venereology. Sep2023, Vol. 37 Issue 9, p1694-1696. 3p.

Installing oncofertility programs for breast cancer in limited versus optimum resource settings: Empirical data from 39 surveyed centers in Repro-Can-OPEN Study Part I & II.

Authors: Salama, Mahmoud Lambertini, M. Christianson, MS et al.

Source: Journal of Assisted Reproduction & Genetics. Feb2022, Vol. 39 Issue 2, p505-516. 12p.

Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines†.

Authors: Lambertini, M. Peccatori, F.A. Demeestere, I. et al.

Source: Annals of Oncology. Dec2020, Vol. 31 Issue 12, p1664-1678. 15p.

Mohs micrographic surgery for nail unit tumours: an update and a critical review of the literature.

Authors: Lambertini, M. Piraccini, B.M. Fanti, P.A. et al.

Source: Journal of the European Academy of Dermatology & Venereology. Oct2018, Vol. 32 Issue 10, p1638-1644. 7p.

302P Perceptions of women with HER2+ breast cancer on the risk of recurrence and disease management: Results from the ASKHER survey.

Authors: Lambertini, M. Tredan, O. Losada, M.J. Vidal et al.

Source: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS341-S341. 1p.

Oral melanoma and other pigmentations: when to biopsy?

Authors: Lambertini, M. Patrizi, A. Fanti, P.A. et al.

Source: Journal of the European Academy of Dermatology & Venereology. Feb2018, Vol. 32 Issue 2, p209-214. 6p. 7 Color Photographs, 2 Charts.

Reproductive potential and performance of fertility preservation strategies in BRCA-mutated breast cancer patients.

Authors: Lambertini, M Goldrat, O Ferreira, A R et al.

Source: Annals of Oncology. Jan2018, Vol. 29 Issue 1, p237-243. 7p. 2 Charts, 1 Graph.

Nail involvement as a negative prognostic factor in biological therapy for psoriasis: a retrospective study.

Authors: Bardazzi, F. Lambertini, M. Chessa, M.A. et al.

Source: Journal of the European Academy of Dermatology & Venereology. May2017, Vol. 31 Issue 5, p843-846. 4p.

'Scaly' tattoo reactions: is treatment mandatory?

Authors: Lambertini, M. Dika, E. Ravaioli, G. M. et al.

Source: Clinical & Experimental Dermatology. Apr2017, Vol. 42 Issue 3, p347-348. 2p.

Ovarian suppression using luteinizing hormonereleasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies.

Authors: Lambertini, M. Ceppi, M. Poggio, F. et al.

Source: Annals of Oncology. Dec2015, Vol. 26 Issue 12, p2408-2419. 12p. 1 Diagram, 6 Charts, 1 Graph.

This result is not displayed to guests.
Login for full access.

Gonadotropin-releasing hormone analogs for ovarian function protection during chemotherapy in young early breast cancer patients: the last piece of the puzzle?

Authors: Del Mastro, L. Lambertini, M.

Source: Annals of Oncology. Aug2017, Vol. 28 Issue 8, p1683-1685. 3p.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Large plaque‐type blue naevus with cellular nodules: a rare unrecognized melanocytic tumour.

Authors: Baraldi, C. Lambertini, M. Fanti, P. A. et al.

Source: Journal of the European Academy of Dermatology & Venereology. Apr2018, Vol. 32 Issue 4, pe132-e133. 2p.

95TiP Gruppo Italiano Mammella (GIM) 10 – CONSENT: A phase III randomized study comparing concurrent versus sequential administration of adjuvant chemotherapy (CT) and aromatase inhibitors (AIs) in post-menopausal patients (pts) with hormone receptor-positive (HR+) early breast cancer (EBC)

Authors: Lambertini, M. Guarneri, V. Caremoli, E.R. et al.

Source: Annals of Oncology. 2020 Supplement 2, Vol. 31, pS47-S47. 1p.